Shanghai Fundom International Trading Co., Ltd. (hereinafter referred to as Fundom Int’l) was established in 2017 and located in China (Shanghai) Pilot Free Trade Zone. Fundom Int’l is the Capitalization Subsidiary Company of Amicogen China.
Adhering to the operation philosophy of Tolerant to Diversity &Persist in Capability, Fundom Int’l has been expanding its business on a basis of pharmaceutical and turned into a comprehensive import and export corporation specialized in pharmaceutical, chemical, healthcare and cosmetics products, medical apparatus and instruments and technologies. Fundom Int’l devotes continuously to exporting the superior products of China to the world and importing new products, advanced technologies and experiences of management and administration.
Amicogen (China) Biopharm Co., Ltd., the parent company, located in Jining city, Shandong province, is a Sino-foreign joint venture focused on develop, manufacture and marketing of pharmaceuticals, bio-engineering products, API and formulation both for human and animal use, pharmaceutical resins. With USD 12 million’s registered capital and USD 70 million’s aggregate investment, Amicogen (China) is a powerful technical and financial supporter to the development of Fundom Int’l.
With abundant experiences accumulated in practice in international bidding and trading, Fundom Int’s has built extensive partnership with the international business, industrial, scientific and technological, and financial circles by its consistency in international trade practices, thus the Chinese market is tightening up to the international market with the business ties. Fundom Int’s is ready for sincere cooperation and mutual development with domestic and foreign friends.